Source: StreetInsider

Press Release: BIOCORP : BIOCORP Obtains 510(k) FDA Clearance for SoloSmart, Sanofi's Smart Cap for Disposable Insulin Pens

In addition to SoloSmart's CE marking (Sept 2022), the FDAs authorization reinforces BIOCORP's technological leadership in the smart pens market. This is the second FDA clearance1 for Biocorps Mallya...

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
Eric Dessertenne's photo - CEO of BIOCORP

CEO

Eric Dessertenne

CEO Approval Rating

90/100

Read more